Previous close | 142.26 |
Open | 141.81 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 137.01 - 143.67 |
52-week range | 80.04 - 144.31 |
Volume | 113,759 |
Avg. volume | 136,162 |
Market cap | 2.938B |
Beta | 0.76 |
PE ratio (TTM) | 144.26 |
EPS (TTM) | 0.96 |
Earnings date | 30 Apr 2018 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 146.60 |
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2018 financial results after market close on Monday, April 30, 2018.
The company, which makes portable devices that supply oxygen to patients with breathing difficulties and lung diseases, said some non-public financial information was also leaked after an employee's email account was compromised. The unauthorized access appeared to have occurred between Jan. 2 and March 14 and involved rental customers' personal information such as names, contact details, Medicare identification numbers and insurance policy information.
The company, which makes portable devices that supply oxygen to patients with breathing difficulties and lung diseases, said some non-public financial information was also leaked after an employee's email account was compromised. The unauthorized access appeared to have occurred between Jan. 2 and March 14 and involved rental customers' personal information such as names, contact details, Medicare identification numbers and insurance policy information.
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 17th Annual Needham Healthcare Conference in New York City.
Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.
On a per-share basis, the Goleta, California-based company said it had a loss of 3 cents. Earnings, adjusted for pretax expenses, came to 31 cents per share. The results surpassed Wall Street expectations. ...
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-month periods ended December 31, 2017.
Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.
Inogen (INGN) rides on POC growth. Existing market challenges likely to mar prospects.
Here's What's in Store for Globus Medical in 2018
Globus Medical (GMED) recently launched a robotic surgical navigation device. Since its inception in 2003, Globus Medical has launched more than 180 products. Globus Medical acquired KB Medical, a Switzerland-based robotic developer, in June 2017.
Globus Medical (GMED) is a medical device company with a focus on designing, developing, and commercializing musculoskeletal solutions. Globus Medical’s sales force is comprised of direct sales representatives and distributor sales representatives employed by exclusive independent distributors. Of the 13 analysts covering Globus Medical in February 2018, seven of them have given the stock a “buy” or higher rating.
Why Investors Are Eyeing MiMedx Group Today
Why Investors Are Eyeing MiMedx Group Today
Why Investors Are Eyeing MiMedx Group Today
Why Investors Are Eyeing MiMedx Group Today
MiMedx Group (MDXG) operates in the regenerative biomaterials segment. MiMedx is a leading global supplier of amniotic tissue products and has supplied over a million allografts in wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. Of the four analysts covering MiMedx Group in January 2018, three have given the stock a “buy” rating, and one analyst has given it a “strong buy” rating.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Leerink Partners 7th Annual Global Healthcare Conference in New York City.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2017 financial results after market close on Tuesday, February 27, 2018.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 36th Annual J.P.
Inogen's (INGN) expanding product portfolio is a key catalyst. Foreign exchange headwinds continue to hurt the company's growth trajectory.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 29th Annual Piper Jaffray Healthcare Conference in New York City.
Inogen's (INGN) unique direct-to-customer business model has lent it a leading position in the United States.